Filing Details
- Accession Number:
- 0001596783-17-000150
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-31 11:41:26
- Reporting Period:
- 2017-08-29
- Accepted Time:
- 2017-08-31 10:41:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1596783 | Catalent Inc. | CTLT | Pharmaceutical Preparations (2834) | 208737688 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1684273 | Christine Dolan | C/O Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873 | Svp - Product Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-08-29 | 9,150 | $18.57 | 27,007 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-08-29 | 5,964 | $38.75 | 21,043 | No | 4 | F | Direct | |
Common Stock | Disposition | 2017-08-29 | 1,594 | $38.75 | 19,449 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options to purchase Common Stock | Disposition | 2017-08-29 | 9,150 | $0.00 | 9,150 | $18.57 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
34,287 | 2022-05-25 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
- Includes restricted stock units.
- On May 25, 2012, the reporting person was granted options to purchase common stock of the Issuer, which options began to vest and become exercisable upon the passage of time and, in certain cases, the satisfaction of performance criteria beginning April 1, 2013.